Infeflox

Ceftriaxone, the active ingredient in Infeflox, is a third‑generation cephalosporin presented as an injectable for intramuscular and intravenous use. It treats a broad range of serious bacterial infections in adults and children, including pneumonia, meningitis, gonorrhea, urinary and skin infections, and intra‑abdominal infections.

GNH USA supplies Infeflox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable global logistics for healthcare providers. Customers benefit from consistent product availability, regulatory compliance, and dedicated technical support.

Ceftriaxone is a broad‑spectrum cephalosporin used to treat bacterial infections across several organ systems.

- Community‑acquired pneumonia: effective eradication of the causative pathogens, leading to clinical improvement and reduced mortality. - Bacterial meningitis: rapid bactericidal activity in cerebrospinal fluid, helping to resolve infection and prevent complications. - Gonorrhea: single‑dose therapy that eliminates Neisseria gonorrhoeae and reduces transmission risk. - Urinary tract infections: clears susceptible uropathogens, relieving symptoms and preventing upper‑tract spread. - Skin and soft tissue infections: treats Staphylococcus and Streptococcus species, promoting wound healing. - Intra‑abdominal infections: covers mixed aerobic and anaerobic organisms, supporting recovery after surgery or perforation.

Ceftriaxone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain - Diarrhea - Rash

Serious or Rare Side Effects: - Anaphylaxis - Clostridioides difficile‑associated colitis - Stevens‑Johnson syndrome

When using Infeflox, clinicians should consider several safety measures.

- Assess renal function: adjust use in patients with severe renal impairment. - Monitor liver enzymes: discontinue if significant hepatotoxicity develops. - Check for hypersensitivity: avoid in individuals with known cephalosporin allergy. - Use with caution in neonates: avoid calcium‑containing solutions to prevent precipitation. - Evaluate for biliary sludging: monitor patients with gallbladder disease. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze.

Ceftriaxone interacts with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Calcium‑containing solutions in neonates: can precipitate ceftriaxone. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Aminoglycosides: antagonistic effect reducing bactericidal activity.

Moderate Interactions (Monitor Closely): - Probenecid: decreases renal clearance, raising ceftriaxone levels. - Diuretics: may increase risk of renal dysfunction. - Oral contraceptives: possible reduction in efficacy, consider alternative contraception.